NIH-funded research R01 grant

X chromosome inactivation: how it stays quiet in female immune cells

Official title: Role for nuclear matrix proteins and DNA methylation for XCI maintenance in female lymphocytes

Funded at University of Pennsylvania · NIH-11360631 · Data updated 2026-11-12

This grant studies how X-linked gene silencing works in female immune cells and how failures may contribute to lupus.

More Female research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 7, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$528,479
NIH project number5R01AI168047-04
Project IDNIH-11360631 on NIH RePORTER

Who could benefit from this research

Could help

Women with autoimmune lupus risk or established SLE who could contribute blood or B cell samples for analysis.

Less likely to help

Individuals not affected by lupus or without access to relevant samples may see no direct benefit.

What this research studies

In this project, researchers at the University of Pennsylvania will investigate how X chromosome inactivation is maintained in female B cells and how changes in DNA methylation and nuclear matrix proteins affect this process. They will look at Xist RNA behavior, methylation patterns, and the role of proteins like hnRNPU and SAFB in keeping the Xi quiet. The work combines cell studies from human samples with molecular analyses to understand why certain women are more prone to autoimmune lupus. Findings could point to new targets for predicting risk or guiding therapies for lupus patients. This research is grounded in human biology and aims to translate basic insights into potential clinical advances.

Why it matters

Potential benefit: Understanding XCI maintenance could lead to better understanding of lupus risk and avenues for future diagnostics or treatments.

How similar studies have gone: Prior work shows abnormal X-linked gene expression in SLE B cells, suggesting this area is promising but still exploratory.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Anguera, Montserrat C — University of Pennsylvania
  • Study coordinator: Anguera, Montserrat C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.